Same Indication

Nivolumab vs Propranolol

Nivolumab vs Propranolol: Overview

This comparison examines the pharmacological differences between Nivolumab and Propranolol.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Propranolol: Non-selective beta-adrenergic receptor blocker.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Propranolol — 3-6 hours.

Chemical Properties

Molecular Formula: Propranolol — C16H21NO2.

Molecular Weight: Propranolol — 259.3440 g/mol.

Type: Nivolumab — Antibody; Propranolol — Small molecule.